
You can double your weight loss by ditching this cancer-causing food from your diet: study
Participants lost twice as much weight when they adhered to a diet of minimally processed foods (MPFs) compared to one that included ultra-processed foods (UPFs).
UPFs — billed as ready to eat or heat — typically undergo several processing steps, feature additives and preservatives and contain high levels of sodium, refined sugars and cholesterol-spiking fats.
3 Participants in a new study lost twice as much weight when they adhered to a diet of minimally processed foods (MPFs) compared to one that included ultra-processed foods (UPFs).
beats_ – stock.adobe.com
A recent study linked UPF exposure to 32 poor health outcomes, including a higher risk of cardiovascular disease, cancer, metabolic syndrome, obesity, non-alcoholic fatty liver disease, Type 2 diabetes and even premature death.
In this latest trial, the UPFs were relatively 'healthy.' Items included store-bought breakfast cereal, granola bars, fruit snacks, flavored yogurt cups, instant noodles and ready-made lasagna.
By contrast, participants on the MPF diet were fed catered meals of overnight oats with fresh fruit, plain yogurt with toasted oats and fruit, handmade fruit and nut bars, freshly made chicken salad, homemade stir fry and spaghetti Bolognese.
While processing levels differed wildly between the two diets, portions and nutritional content were similar.
Researchers matched the diets for calories, sugar, fat, fiber and micronutrients. Both aligned with dietary guidance from the UK government, called the Eatwell Guide (EWG).
Participants lost weight on both diets, but considerably more when they abstained from UPFs. At the end of the eight-week trial, participants on the MPF diet lost 2% of their body weight compared to a 1% loss from the UPF diet.
3 Participants lost weight on both diets but considerably more when they abstained from UPFs.
ISO101 – stock.adobe.com
The results were published this week in the journal Nature Medicine.
While these numbers are small, the trial period was relatively short. When extrapolated over a year, participants on an MPF diet would lose between 9% and 13% of their weight, while those who adhered to the UPF diet would drop 4% to 5%.
In addition to more pounds shed, the MPF diet also correlated to more fat loss, fewer cravings and lower triglycerides.
'Choosing less processed options such as whole foods and cooking from scratch, rather than ultra-processed, packaged foods or ready meals, is likely to offer additional benefits in terms of body weight, body composition and overall health,' said senior study author Rachel Batterham from the UCL Centre for Obesity Research.
Researchers believe some of the weight loss can be attributed to people eating less on the MPF diet since UPFs are 'hyperpalatable.'
Despite the known risks, UPFs can be a tough habit to kick since they have been engineered for convenience and cravings, with a combination of flavors and additives designed to encourage addictive eating behavior.
Comparatively, participants scored the MPF diet lower in taste and flavor ratings, suggesting that they ate less because the food was less compelling and addictive.
3 While processing levels differed wildly between the two diets, portions and nutritional content were similar.
Allistair F/peopleimages.com – stock.adobe.com
Still, researchers noted that people were able to lose weight on the UPF diet, contradicting previous claims that UPFs inhibit weight loss.
Batterham maintains that this is owed in part to this particular UPF diet following nutritional guidelines.
'The best advice to people would be to stick as closely to nutritional guidelines as they can by moderating overall energy intake, limiting intake of salt, sugar and saturated fat and prioritizing high-fiber foods such as fruits, vegetables and nuts,' she said.
One situation in which UPFs may edge out their whole food competition? Plant-based meat replacement products.
The new study findings come as packaged foods and frozen meals persist in US diets, with recent research revealing that a shocking 60% of Americans' daily caloric intake comes from UPFs.
While UPFs may not completely sabotage weight loss, they can contribute to a slew of health problems.
A recent study suggested that some UPFs may contain a disturbing amount of microplastics, which are potentially harmful to respiratory, reproductive and mental health.
UPF consumption has also been linked to an increased risk of lung cancer.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
a day ago
- Time Business News
D-Dimer Test Flags Clot Risk, Aids Broader Diagnosis
D Dimer Test is a kind of blood test detecting the presence of D-dimer in the blood. D-dimer is a protein fragment of fibrin formed after Fibrinolysis degradation of blood clot. It is helpful to diagnose the conditions with abnormal blood clots formation and breakdown, intravascular fibrinolysis, and coagulation. High D-dimer levels indicate clinical suspicion of a blood clot and needs ultrasound, CT angiography, scans could be performed to confirm the presence of clot and location of clot. D-Dimer test is not specific to any disease. D-Dimer test is not specific to any disease and thus is performed in conjunction with other evaluations and diagnostic tests. 0.5 is measured as normal range for D-dimer and greater than 0.5 is measured to be positive. D-dimer decreases under abnormal medical case which is measured by specific antibodies. Key Growth Drivers and Opportunities Demand for D-Dimer Testing: Traditional testing is replaced by D-dimer testing, allowing for faster test results, quicker diagnosis, shorter patient wait times, and better patient outcomes overall. D-Dimer testing to be more widely used by customers offering compelling advantages. Moreover, the growing prevalence of lung and cardiovascular illnesses might, in extreme circumstances, lead to potentially fatal blood clot problems, which propels D-Dimer Test. Rising Genetic Disorders: Increasing cases of Thrombus embolism along with various cardiovascular and pulmonary diseases that could be life threating due to clot formation increases the demand for D-Dimer Test globally. D-dimer functions as valuable marker in various clinical conditions such as HIV, atrial fibrillation, coronary artery disease. New technological advancement such as development of aptamers, reducing use of antibodies for D-dimer testing being cost-effective, long-lasting boosts D-Dimer Test widening scope for these tests. Challenges The major challenge consists of inadequate skilled professionals and trained professionals unable to perform the test properly and lack of knowledge leads to false results and restrains the D-Dimer test Market. High cost and poor reimbursement policies restrains people to take such tests for proper diagnosis increasing the prevalence of disease and deaths. Innovation and Expansion Study Links Long COVID Brain Fog to Blood Microclots In September 2023, Finding was published in Nature Medicine, suggesting links between brain fog in long COVID and 'micro clots' in the blood. These clots often contain misfolded fibrinogen proteins that prevent the clots from breaking down, and this effect can clog blood vessels and block oxygen flow to the brain and other organs. Blood tests for both D-dimer and fibrinogen are already standard around the world, so researchers had plenty of available data to check whether the same phenomenon occurred in other groups of patients. LumiraDx Expands Rapid Testing for VTE and Heart Failure In June 2022, LumiraDx Limited, a next-generation point of care Diagnostics Company, announced its cardiovascular offering with a CE Mark for its new NT-proBNP test to aid in the diagnosis of CHF and an updated CE Mark for its D-Dimer test to now rule out venous thromboembolism (VTE) in symptomatic patients. With these two additions, the LumiraDx Platform can further support clinicians in quickly and accurately assessing patient symptoms for both VTE and heart failure at the point of care. The LumiraDx NT-proBNP test is a rapid microfluidic immunofluorescence assay for the quantitative measurement of NT-proBNP in human capillary, venous whole blood and plasma specimens. Inventive Sparks, Expanding Markets The major companies present in the D-dimer test market are Bio/Data Corporation, Becton Dickinson BV, Sysmex Corporation, Abbott Laboratories, Inc., Dickinson and Company, Hoffman-La Roche Ltd., among others. Global companies work to foster lasting innovation, grow their markets, and provide quality goods and services. They concentrate on improving customer experience, applying tech, and creating strong operations. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS


Axios
2 days ago
- Axios
Off-the-shelf vaccine shows success against deadly cancers
An experimental vaccine targeting one of the most common genetic drivers of hard-to-treat pancreatic and colorectal cancers prevented their recurrence, raising hopes for an "off the shelf" treatment that can train the immune system to attack malignancies. Why it matters: If shown effective in further trials, the vaccine could become a particularly important tool in staving off the return of pancreatic cancer, which sees roughly 80% of surgically removed tumors recur within five years. What they're saying:"This was a trial all of us in the medical oncology world have been waiting for," said Tracy Proverbs-Singh, an oncologist at Hackensack Meridian's John Theurer Cancer Center. "We see these patients for five years, we see the recurrences, we have to re-treat them, and it's devastating. And after we finish chemo, there's not a lot we can do." Go deeper: The peptide vaccine targets the KRAS mutation that occurs in roughly 90% of pancreatic cancers and half of colorectal cancers. Researchers administered the shot, called ELI-002 2P, to 25 patients who'd received conventional treatments but still had small amounts of cancer left in their bodies and were at high risk of relapse. Half of patients had no relapse by 16.3 months, and median overall survival was 28.9 months — both exceeding historical norms, per the study in Nature Medicine. The greatest benefit was seen in patients who had strong T cell responses. At the 20-month mark, 17 of the 25 patients had strong immune responses with 11 of those patients having no recurrence and six having delayed recurrence. The latter successfully underwent further treatment. "All the 17 were still alive which is why we think there's optimistically, something real going on here, because that's much better than what we might have expected historically," said Zev Wainberg, co-director of the UCLA GI Oncology Program and one of the lead authors. Yes, but: Researchers do not yet understand why eight of the 23 patients did not develop a strong immune response as a result of the vaccine. Between the lines: Much of the enthusiasm around therapeutic cancer vaccines has centered on personalized mRNA technology. It is notable that researchers were able to use a non-personalized vaccine because it can be more easily developed at scale. "It's a big shot in the arm for the pancreatic cancer vaccine, which has been elusive in the context of us being able to get something that's effective in the early stages," said Madappa Kundranda, division chief for cancer medicine at Banner MD Anderson Cancer Center. Reality check: This is still a small Phase 1 trial and will require a more robust randomized controlled trial. Wainberg said the team has already completed such a trial and should have results back in 2026. What to watch: Pancreatic cancer, which has a five-year survival rate of around 13% in the U.S., could be treated very differently within the next two years as multiple new drugs targeting the same mutations are also developed.
Yahoo
2 days ago
- Yahoo
This diet led to twice the fat loss in 8 weeks
Ah, UPFs (ultra-processed foods) – you're likely tired of hearing about them now. But, as they're increasingly linked to poor health outcomes like cardiovascular disease, obesity, diabetes, some types of cancer and depression, the extensive coverage is generally well-deserved. And now, in the longest ever experimental study of a UPF diet, researchers have highlighted how food processing, not just nutrients, can affect body weight and health outcomes. What did the study find? Led by researchers at UCL and UCLA, the study compared a minimally processed diet (meals included overnight oats or homemade bolognese) with an ultra-processed diet (think breakfast oat bars and ready-made lasagne). The researchers split 55 adults into two groups, with each group completing one eight-week diet before switching to the other after a washout period, during which they followed their normal diet. Both diets followed the Eatwell Guide – the UK's official government advice on how to eat a healthy, balanced diet. Participants were sent more than enough food and told to eat as they normally would – with no restriction. Interestingly, after eight weeks on the diet, both groups lost weight, potentially due to the improved nutritional profile of what they were eating compared to their normal diet. However, on the MPF diet, participants experienced a 2.06% reduction compared to a 1.05% reduction on the UPF diet. In other words, they lost twice as much weight. What's more, the greater weight loss on the MPF diet came from reduced fat mass and total body water with no change in muscle or fat-free mass, suggesting a healthier body composition overall. 'Though a 2% reduction may not seem very big, that is only over eight weeks and without people trying to actively reduce their intake,' the study's lead author Dr Samuel Dicken said of the results. If we scaled these results up over the course of a year, we'd expect to see a 13% weight reduction in men and a 9% reduction in women on the minimally processed diet.' What does this mean for us? The findings suggest that following a diet containing mostly minimally processed food supports sustainable weight loss. This makes sense since such foods tend to be more satiating and less energy-dense, which can often lead to people eating less naturally without restricting in any way. Indeed, the researchers also found that there were significantly greater improvements in the number of cravings and ability to resist them on the MPF diet compared to the UPF diet. It's certainly not to say UPF bars and snacks (which can be useful sources of fuel, especially in a workout context) are off-limits. In fact, the findings support the idea that not all UPFs are inherently unhealthy – particularly when they adhere to appropriate nutritional guidelines. The bottom line To further consolidate these results, as is often the case, more research is needed and on a larger scale. However, considering this was the first ever interventional study comparing UPF and MPF diets, the findings are valuable and demonstrate just how powerful a role food and nutrition can play in supporting sustainable weight loss and healthy body composition. You Might Also Like 13 Buys To Help You Feel Great From £5 16 Speedo Swimsuits that Won't Flash Your Bum When Getting Swim-fit 11 Best Gym Trainers for Different Types of Workouts